Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.11B
| $1.09M | ﹤0.01% |
26,700
-22,600
| -46% | -$896K |
|
|
ADAP
2352
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.09M | ﹤0.01% |
1,370,239
+342,379
| +33% | +$193K |
|
2353
908 Devices
MASS
$414M
| $1.09M | ﹤0.01% |
96,900
+12,200
| +14% | +$83.4K |
|
|
PPLT
2354
abrdn Physical Platinum Shares ETF
PPLT
$2.04B
| $1.08M | ﹤0.01% |
119,000
-9,000
| -7% | -$75.9K |
|
|
AAN
2355
DELISTED
The Aaron's Company Inc
AAN
| $1.08M | ﹤0.01% |
99,400
-54,900
| -36% | -$510K |
|
2356
Calix
CALX
$2.49B
| $1.08M | ﹤0.01% |
24,700
-127,053
| -84% | -$5.08M |
|
2357
Farmers National Banc Corp
FMNB
$966M
| $1.08M | ﹤0.01% |
74,684
-23,600
| -24% | -$291K |
|
2358
Heritage Global
HGBL
$37.9M
| $1.08M | ﹤0.01% |
387,278
-65,439
| -14% | -$193K |
|
2359
Zumiez
ZUMZ
$314M
| $1.08M | ﹤0.01% |
+52,900
| New | +$948K |
|
2360
Invesco S&P 500 Revenue ETF
RWL
$10B
| $1.07M | ﹤0.01% |
+12,600
| New | +$1.01M |
|
|
MAPS
2361
DELISTED
WM TECHNOLOGY INC A
MAPS
| $1.07M | ﹤0.01% |
1,490,300
+928,724
| +165% | +$923K |
|
|
TGH
2362
DELISTED
Textainer Group Holdings limited
TGH
| $1.06M | ﹤0.01% |
21,600
-61,400
| -74% | -$2.83M |
|
2363
Origin Bancorp
OBK
$1.68B
| $1.06M | ﹤0.01% |
29,800
-4,500
| -13% | -$143K |
|
|
VTYX
2364
DELISTED
Ventyx Biosciences
VTYX
| $1.06M | ﹤0.01% |
+429,200
| New | +$4.08M |
|
2365
Mercer International
MERC
$31.6M
| $1.06M | ﹤0.01% |
111,711
-101,800
| -48% | -$913K |
|
|
KLG
2366
DELISTED
WK Kellogg Co
KLG
| $1.06M | ﹤0.01% |
+80,455
| New | +$905K |
|
2367
Ascent Industries
ACNT
$136M
| $1.06M | ﹤0.01% |
110,511
+911
| +0.8% | +$7.5K |
|
2368
Aldeyra Therapeutics
ALDX
$94.1M
| $1.05M | ﹤0.01% |
300,000
+78,200
| +35% | +$241K |
|
2369
First US Bancshares
FUSB
$90.6M
| $1.05M | ﹤0.01% |
102,021
-1,700
| -2% | -$15.2K |
|
2370
World Kinect Corp
WKC
$1.85B
| $1.05M | ﹤0.01% |
46,200
-110,439
| -71% | -$2.32M |
|
2371
Amylyx Pharmaceuticals
AMLX
$2.41B
| $1.05M | ﹤0.01% |
71,288
-78,812
| -53% | -$1.21M |
|
|
TAIT
2372
DELISTED
Taitron Components
TAIT
| $1.05M | ﹤0.01% |
297,204
-9,517
| -3% | -$33.1K |
|
2373
Yatra Online
YTRA
$58.6M
| $1.05M | ﹤0.01% |
643,708
-9,113
| -1% | -$15K |
|
2374
Dine Brands
DIN
$447M
| $1.05M | ﹤0.01% |
+21,100
| New | +$1M |
|
2375
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$271M
| $1.05M | ﹤0.01% |
+50,643
| New | +$1.05M |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.